Clinical Trial Update: Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating combination chemotherapy with or without rituximab in newly diagnosed non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: University of Nebraska | Conditions: Lymphoma | Phase 3 | Status: COMPLETED